MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...
Hologic (HOLX) has been drawing fresh attention after a mix of modest short term moves and stronger past 3 months returns, prompting investors to reassess how its current valuation lines up with ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) yesterday presented new research demonstrating the performance of its Genius AI ® Detection 2.0 software across diverse patient ...
Hologic, Inc. is down approximately 20% from recent highs despite strong quarterly results. The company continues to grow organically and via a series of 'bolt-on' acquisitions. Management also ...
Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...
Last Friday, Hologic HOLX appointed finance veteran Wayde McMillan to its board of directors and also to the Audit and Finance Committee. Mr. McMillan’s extensive leadership experience includes ...
Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Hologic (NASDAQ:HOLX) in the last three months. The following table provides a quick overview of ...
Hologic, Inc. HOLX is gaining from continued strength in GYN Surgical and Breast Health businesses. The company’s focus on international operations is encouraging. Strong solvency is an added ...
Hologic Stockholders to Receive $76 per Share in Cash Plus a Contingent Value Right of up to $3 per Share Payable Upon Achieving Certain Revenue Milestones Represents 46% Premium to Hologic’s Closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback